Response to statin therapy in obstructive sleep apnea syndrome: A multicenter randomized controlled trial

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Joyeux Faure, Marie ^a,b   Tamisier, Renaud ^a,b   Baguet, Jean Philippe ^b   Dias Domingos, Sonia ^a,b   Perrig, Stephen ^c   Leftheriotis, Georges ^d   Janssens, Jean Paul ^e   Trzepizur, Wojciech ^d,f   Launois, Sandrine H ^a,b   Stanke Labesque, Françoise ^a,b   Lévy, Patrick A ^a,b   Gagnadoux, Frédéric ^d,f   Pepin, Jean Louis ^a,b  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c Hôpital Belle Idèe   (Switzerland)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE;

ADULT; ARTERIAL STIFFNESS; ARTERY TONE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; MULTICENTER STUDY; MYALGIA; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; AGED; ATHEROSCLEROSIS; BLOOD PRESSURE; CLINICAL TRIAL; DRUG EFFECTS; METABOLISM; SLEEP APNEA, OBSTRUCTIVE;

ADULT; AGED; ATHEROSCLEROSIS; ATORVASTATIN CALCIUM; BLOOD PRESSURE; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PYRROLES; SLEEP APNEA, OBSTRUCTIVE;

EID: 84930009164     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/423120     Document Type: Article

References (48)

1. P. Levy, J. L. Pepin, C. Arnaud, J. P. Baguet, M. Dematteis, and F. Mach, "Obstructive sleep apnea and atherosclerosis, " Progress in Cardiovascular Diseases, vol. 51, pp. 400-410, 2009.
2. J. Baguet, G. Barone-Rochette, R. Tamisier, P. Levy, and J. Pepin, "Mechanisms of cardiac dysfunction in obstructive sleep apnea, " Nature Reviews Cardiology, vol. 9, no. 12, pp. 679-688, 2012.
3. F. Barbe, J. Duran-Cantolla, M. Sanchez-de-la-Torre et al. , "Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial, " Journal of the AmericanMedical Association, vol. 307, no. 20, pp. 2161-2168, 2012.
4. J. Baguet, L. Hammer, P. Levy et al. , "The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence, " Chest, vol. 128, no. 5, pp. 3407-3412, 2005.
5. L. F. Drager, L. A. Bortolotto, M. C. Lorenzi, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho, "Early signs of atherosclerosis in obstructive sleep apnea, " The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 5, pp. 613-618, 2005.
6. K. Minoguchi, T. Yokoe, T. Tazaki et al. , "Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea, " The American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 5, pp. 625-630, 2005.
7. L. Lavie and P. Lavie, "Molecularmechanisms of cardiovascular disease in OSAHS: the oxidative stress link, " European Respiratory Journal, vol. 33, no. 6, pp. 1467-1484, 2009.
8. J. L. Pepin, R. Tamisier, J. Baguet, and P. Levy, "Arterial health is related to obstructive sleep apnea severity and improves with CPAP treatment, " Sleep Medicine Reviews, vol. 17, no. 1, pp. 3-5, 2013.
9. S. Itzhaki, L. Lavie, G. Pillar, G. Tal, and P. Lavie, "Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia, " Sleep, vol. 28, no. 5, pp. 594-600, 2005.
10. M. Kohler, S. Craig, D. Nicoll, P. Leeson, R. J. O. Davies, and J. R. Stradling, "Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea, " The American Journal of Respiratory and Critical CareMedicine, vol. 178, no. 9, pp. 984-988, 2008.
11. T. Kizawa, Y. Nakamura, S. Takahashi, S. Sakurai, K. Yamauchi, and H. Inoue, "Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea, " European Respiratory Journal, vol. 34, no. 6, pp. 1390-1398, 2009.
12. G. E. Foster, P. J. Hanly, S. B. Ahmed, A. E. Beaudin, V. Pialoux, and M. J. Poulin, "Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism, " Hypertension, vol. 56, no. 3, pp. 369-377, 2010.
13. J. E. Deanfield, J. P. Halcox, and T. J. Rabelink, "Endothelial function and dysfunction: testing and clinical relevance, " Circulation, vol. 115, no. 10, pp. 1285-1295, 2007.
14. A. J. Flammer, T. Anderson, D. S. Celermajer et al. , "The assessment of endothelial function: From research into clinical practice, " Circulation, vol. 126, no. 6, pp. 753-767, 2012.
15. N. M. Hamburg, M. J. Keyes, M. G. Larson et al. , "Crosssectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study, " Circulation, vol. 117, no. 19, pp. 2467-2474, 2008.
16. R. Rubinshtein, J. T. Kuvin, M. Soffler et al. , "Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events, " European Heart Journal, vol. 31, no. 9, pp. 1142-1148, 2010.
17. L. F. Drager, L. A. Bortolotto, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho, "Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea, " The American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 7, pp. 706-712, 2007.
18. M. Kohler, A. C. Stoewhas, L. Ayers et al. , "Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial, " American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 10, pp. 1192-1199, 2011.
19. T. E. Weaver and R. R. Grunstein, "Adherence to continuous positive airway pressure therapy: the challenge to effective treatment, " Proceedings of the AmericanThoracic Society, vol. 5, no. 2, pp. 173-178, 2008.
20. J. A. Chirinos, I. Gurubhagavatula, K. Teff et al. , "CPAP, weight loss, or both for obstructive sleep apnea, " The New England Journal of Medicine, vol. 370, pp. 2265-2275, 2014.
21. L. Gao, W. Wang, Y. Li et al. , "Simvastatin therapy normalizes sympathetic neural control in experimental heart failure: roles of angiotensin II type 1 receptors and NAD(P)H oxidase, " Circulation, vol. 112, no. 12, pp. 1763-1770, 2005.
22. P. Totoson, W. Fhayli, G. Faury et al. , "Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia, " Experimental Biology and Medicine, vol. 238, no. 2, pp. 223-232, 2013.
23. K. Ferrier, M. Muhlmann, J. Baguet et al. , "Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension, " Journal of the American College of Cardiology, vol. 39, no. 6, pp. 1020-1025, 2002.
24. C. Arnaud, V. Braunersreuther, and F. Mach, "Toward immunomodulatory and anti-inflammatory properties of statins, " Trends in Cardiovascular Medicine, vol. 15, no. 6, pp. 202-206, 2005.
25. S. E. Nissen, E. M. Tuzcu, P. Schoenhagen et al. , "Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease, " The New England Journal of Medicine, vol. 352, no. 1, pp. 29-38, 2005.
26. R. Duivenvoorden, J. Tang, D. P. Cormode et al. , "A statinloaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation, " Nature Communications, vol. 5, article 3065, 2014.
27. M. Calvert, J. Blazeby, D. G. Altman, D. A. Revicki, D. Moher, and M. D. Brundage, "Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension, " Journal of the AmericanMedical Association, vol. 309, no. 8, pp. 814-822, 2013.
28. S. Itzhaki, H. Dorchin, G. Clark, L. Lavie, P. Lavie, and G. Pillar, "The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function, " Chest, vol. 131, no. 3, pp. 740-749, 2007.
29. C. Iber, S. Ancoli-Israel, A. Chesson, and S. F. Quan, The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, AmericanAcademy of Sleep Medicine, Westchester, Ill, USA, 2007.
30. R. B. Berry, R. Budhiraja, D. J. Gottlieb et al. , "Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine, " Journal of Clinical SleepMedicine, vol. 8, no. 5, pp. 597-619, 2012.
31. G. Mancia, G. de Backer, and A. Dominiczak, "2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), " Journal of Hypertension, vol. 25, no. 6, pp. 1105-1187, 2007.
32. P. O. Bonetti, G. M. Pumper, S. T. Higano, D. R. Holmes Jr. , J. T. Kuvin, and A. Lerman, "Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia, " Journal of the American College of Cardiology, vol. 44, no. 11, pp. 2137-2141, 2004.
33. I. Vivodtzev, C. Minet, R. Tamisier et al. , "Arterial stiffness by pulse wave velocity in COPD: reliability and reproducibility, " European Respiratory Journal, vol. 42, pp. 1140-1142, 2013.
34. F. Stanke-Labesque, M. Back, B. Lefebvre et al. , "Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia, " Journal of Allergy and Clinical Immunology, vol. 124, no. 2, pp. 364-370, 2009.
35. N. M. Hamburg, J. Palmisano, M. G. Larson et al. , "Relation of brachial and digital measures of vascular function in the community: the framinghamheart study, " Hypertension, vol. 57, no. 3, pp. 390-396, 2011.
36. S. J. Hong, H. J. Chang, S. Park et al. , "Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: a doubleblind, randomized, placebo-controlled crossover trial, " Clinical Cardiology, vol. 36, no. 8, pp. 480-485, 2013.
37. A. M. Tycinska, J. Janica, B. Mroczko et al. , "Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction, " Archives of Medical Science, vol. 7, no. 6, pp. 955-962, 2011.
38. T. Hisada, M. Ayaori, N. Ohrui et al. , "Statin inhibits hypoxiainduced endothelin-1 via accelerated degradation of HIF-1α in vascular smooth muscle cells, " Cardiovascular Research, vol. 95, no. 2, pp. 251-259, 2012.
39. A. Ramond, D. Godin-Ribuot, C. Ribuot et al. , "Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia, " Fundamental and Clinical Pharmacology, vol. 27, no. 3, pp. 252-261, 2013.
40. M. Alajmi, A. T. Mulgrew, J. Fox et al. , "Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials, " Lung, vol. 185, no. 2, pp. 67-72, 2007.
41. J. M. Marin, A. Agusti, I. Villar et al. , "Association between treated and untreated obstructive sleep apnea and risk of hypertension, "The Journal of theAmericanMedical Association, vol. 307, no. 20, pp. 2169-2176, 2012.
42. P. Haentjens, A. van Meerhaeghe, A. Moscariello et al. , "The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials, " Archives of Internal Medicine, vol. 167, no. 8, pp. 757-764, 2007.
43. F. Turnbull, "Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesigned overviews of randomised trials, " The Lancet, vol. 362, no. 9395, pp. 1527-1535, 2003.
44. M. R. Law, J. K. Morris, and N. J. Wald, "Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, " The British Medical Journal, vol. 338, Article IDb1665, 2009.
45. M. R. Law, N. J. Wald, and A. R. Rudnicka, "Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, " British Medical Journal, vol. 326, no. 7404, pp. 1423-1427, 2003.
46. F. Horwood, A. Gruber, J. Sithole, N. Ali, and I. Idris, "Cardiovascular disease risk assessment in patients with obstructive sleep apnoea: clinical utility of the Framingham risk equation for initiating statins, " Diabetes, Obesity and Metabolism, vol. 10, no. 2, pp. 181-182, 2008.
47. J. Pepin, R. Tamisier, and P. Levy, "Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective, " Thorax, vol. 67, no. 12, pp. 1025-1027, 2012.
48. A. L. Borel, J. A. Nazare, J. Smith et al. , "Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program, " Obesity, vol. 20, no. 6, pp. 1223-1233, 2012.